Related references
Note: Only part of the references are listed.Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
Clifford R. Elcombe et al.
TOXICOLOGY (2012)
Bupropion Hydroxylation as a Selective Marker of Rat CYP2B1 Catalytic Activity
Dumrongsak Pekthong et al.
DRUG METABOLISM AND DISPOSITION (2012)
Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes
Joo-Young Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
FDA-approved drug labeling for the study of drug-induced liver injury
Minjun Chen et al.
DRUG DISCOVERY TODAY (2011)
In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
M. J. Gomez-Lechon et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites
Wendy WeiWei Wang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Quantitative Expression Profile of Hepatobiliary Transporters in Sandwich Cultured Rat and Human Hepatocytes
Na Li et al.
MOLECULAR PHARMACEUTICS (2009)
Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and Human
Maryam Rakhshandehroo et al.
PLOS ONE (2009)
T-cadherin modulates hepatocyte functions in vitro
Salman R. Khetani et al.
FASEB JOURNAL (2008)
Microscale culture of human liver cells for drug development
Salman R. Khetani et al.
NATURE BIOTECHNOLOGY (2008)
Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: Correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans
Noriko Masubuchi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies
Nicola J. Hewitt et al.
DRUG METABOLISM REVIEWS (2007)
Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport
Yi-an Bi et al.
DRUG METABOLISM AND DISPOSITION (2006)
A microscale in vitro physiological model of the liver:: Predictive screens for drug metabolism and enzyme induction
A Sivaraman et al.
CURRENT DRUG METABOLISM (2005)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
Cutting the cost of drug development?
MD Rawlins
NATURE REVIEWS DRUG DISCOVERY (2004)
Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling
SR Khetani et al.
HEPATOLOGY (2004)
Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes
MT Donato et al.
DRUG METABOLISM AND DISPOSITION (2004)
Comparison of primary human hepatocytes and hepatoma cell line HEPG2 with regard to their biotransformation properties
S Wilkening et al.
DRUG METABOLISM AND DISPOSITION (2003)
New hepatocyte in vitro systems for drug metabolism: Metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures
R Gebhardt et al.
DRUG METABOLISM REVIEWS (2003)
Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat
K Kobayashi et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
EL LeCluyse
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
